NYSE · A · Diagnostics & Research
Agilent Technologies, Inc. (A) stock analysis
- A gained 6.4% over the past month versus 0.0% for the S&P 500, ranking 140th of 497 S&P 500 stocks.
- Over 12 months it returned +24.8%, 9.0 points ahead of the S&P 500, and trades 0.0% below its 52-week high.
- In the last 30 days 1 analyst raised earnings estimates and 3 cut; forward EPS moved −0.2% (+2.0% over 90 days).
- It sits in the Life-science tools & bioprocessing segment of the Healthcare Value Chain, where the 1-month median return is +6.0%.
- The daily chart reads Intermediate uptrend · High consolidation (since Oct 19, 2026).
One-year price with 50- and 200-day averages
Performance vs the market
Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.
Chart structure
Read by our daily-bar structure engine from swing highs, swing lows and moving averages.
Holding since Oct 19, 2026
- Close above EMA20 above EMA50
- EMA50 rose over the last ten sessions
- Some swings conflict with the averages
38 occurrences in 10 years. The median move over the next 20 sessions was +1.1%, positive 63% of the time, against +1.7% for any day in the same period.
Analyst earnings revisions
Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.
20 analysts cover the stock
Where it sits in the supply chain
Healthcare Value Chain · Tools & research
Instruments, reagents and bioprocessing consumables, following pharma R&D and biologics capacity; biotech funding conditions matter a lot.
Also on: Medtech, Diagnostics & Care
Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps
Risk profile
Track this stock every day
Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.